FDA

Cara Therapeutics Wins Big on FDA Breakthrough

Cara Therapeutics Inc. (NASDAQ: CARA) saw its shares make a handy gain on Friday after the company said that the U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy ...
Read Full Story »

Rigel Pharma Rises Following FDA Approval

Shares of Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) saw a handy uptick on Monday after the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for the use ...
Read Full Story »

How Omeros Won Big on This FDA Approval

Omeros Corp. (NASDAQ: OMER) saw its shares make a handy gain on Tuesday after the company announced that the U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy designation ...
Read Full Story »

Why Akebia Shares Are Hitting New Highs

Akebia Therapeutics Inc. (NASDAQ: AKBA) saw its shares hit a new 52-week high in Tuesday’s session following a key licensing agreement with Vifor Pharma. Specifically this is an exclusive license ...
Read Full Story »

Merck’s Accelerated Keytruda Lung Cancer Approval Creates 3 Moves

It is no secret that pharma and biotech shares have had to deal with at least some headwinds over the past year. It turns out that drug pricing concerns and ...
Read Full Story »

Did Immunomedics Rise Too Much as Seattle Genetics Deal Terminated?

Shares of Immunomedics Inc. (NASDAQ: IMMU) saw a massive gain on Friday after the company announced the termination of its licensing deal with Seattle Genetics Inc. (NASDAQ: SGEN). It may seem ...
Read Full Story »

Intra-Cellular Therapies Sinks on FDA Update

Intra-Cellular Therapies Inc. (NASDAQ: ITCI) saw its stock crumble early on Monday after the company provided an update on its plan to submit a New Drug Application (NDA) for ITI-007 ...
Read Full Story »

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

Big Pharma and Big Biotech sometimes live and die by actions out of the U.S. Food and Drug Administration (FDA). For Eli Lilly and Co. (NYSE: LLY) and Incyte Corp. (NASDAQ: ...
Read Full Story »

Monday’s Top Biopharma Movers

A few biopharma stocks made massive runs on Monday morning. The broad markets are holding near their all-time highs, and part of the run up to this level is attributed ...
Read Full Story »
Female patient on gurney

4 Biopharma Stocks Moving the Market on Wednesday

Markets have hit new intraday highs on Wednesday, continuing to climb in the wake of the White House announcements. Although the health care sector has been attacked by the U.S. ...
Read Full Story »
100 dollar bills

Why Evoke Pharma Shares Are Exploding

Evoke Pharma Inc. (NASDAQ: EVOK) saw its shares make a huge gain on Wednesday after the company issued an update that it received from the U.S. Food and Drug Administration ...
Read Full Story »
Female patient on gurney

Why Amag Pharmaceuticals Is Sinking Despite Positive Top-Line Results

AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) saw its shares take a sharp turn down after the company reported top-line results from its most recent pharmacokinetic (PK) study. The results were ultimately ...
Read Full Story »
Jon's friends

Wednesday’s Top Biopharma Winners

The third week of the New Year is halfway over, and a few biopharma companies made massive runs on the day. The health care sector was in trouble over the ...
Read Full Story »
Medicine pills

Why 3 Analysts Upgraded Merck Simultaneously

It may seem hard to believe that a Big Pharma drug stock might be a favorite for the year ahead when the attacks against drug pricing and competition do not ...
Read Full Story »
Doctor, Health (pulse) copy

Monday’s 4 Biggest Biopharma Movers

The second week of the New Year is now underway, and a few biotech companies made sizable runs to kick off the week. The health care sector was in trouble ...
Read Full Story »